Clinical Trials Directory

Trials / Conditions / Crow's Feet

Crow's Feet

18 registered clinical trials studyying Crow's Feet — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingProspective, Non-interventional Study Assessing Perioral Rejuvenation Procedure
NCT07398768
Yuvell—
CompletedEfficacy and Safety of HMM1-022 in Temporary Correction of Crow's Feet
NCT06428253
Humedix Co., Ltd.N/A
CompletedA Prospective, Non-Interventional, Single-Centre Study Assessing the Efficacy of a Holistic Upper Face Treatme
NCT07374965
Yuvell—
CompletedET-01 in Subjects With Lateral Canthal Lines, LCL-210
NCT04985916
Eirion Therapeutics Inc.Phase 2
UnknownEfficacy and Safety of DKB-119 in Patients in Crow's Feet
NCT06021418
Dongkook Pharmaceutical Co., Ltd.N/A
RecruitingA Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibr
NCT04818203
S.Biomedics Co., Ltd.Phase 1 / Phase 2
CompletedET-01 in Subjects With Lateral Canthal Lines, LCL-209
NCT03912805
Eirion Therapeutics Inc.Phase 2
CompletedET-01 in Subjects With Lateral Canthal Lines, LCL-208
NCT03839693
Eirion Therapeutics Inc.Phase 2
CompletedET-01 in Subjects With Lateral Canthal Lines, LCL-207
NCT03655691
Eirion Therapeutics Inc.Phase 2
CompletedET-01 in Subjects With Lateral Canthal Lines
NCT03326856
Eirion Therapeutics Inc.Phase 2
CompletedDose Finding Study In Subjects With Crow's Feet
NCT01951742
Anterios Inc.Phase 2
CompletedClinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet
NCT01358695
Anterios Inc.Phase 2
CompletedSafety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adu
NCT01124565
Revance Therapeutics, Inc.Phase 2
CompletedA 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Ad
NCT01124552
Revance Therapeutics, Inc.Phase 2
CompletedEfficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
NCT01064518
Revance Therapeutics, Inc.Phase 2
CompletedEfficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT00968942
Revance Therapeutics, Inc.Phase 2
CompletedSafety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT00968825
Revance Therapeutics, Inc.Phase 2
CompletedSafety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT00888914
Revance Therapeutics, Inc.Phase 2